{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:23:41Z","timestamp":1790015021915,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40262-023-01313-8","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:03:40Z","timestamp":1696964620000},"page":"1725-1738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-5897","authenticated-orcid":false,"given":"Angel Luis","family":"Salcedo-Mingoarranz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna Edith","family":"Medell\u00edn-Garibay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Barcia-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito","family":"Garc\u00eda-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"1313_CR1","unstructured":"Brunton LL, Knollmann BC. Goodman & Gilman's: the pharmacological basis of therapeutics, 14th ed. McGraw Hill; 2022."},{"key":"1313_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","volume":"38","author":"K Turnheim","year":"2003","unstructured":"Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38:843\u201353.","journal-title":"Exp Gerontol"},{"issue":"28","key":"1313_CR3","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","volume":"36","author":"M Vamos","year":"2015","unstructured":"Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. Eur Heart J. 2015;36(28):1831\u20138.","journal-title":"Eur Heart J"},{"key":"1313_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s40262-016-0422-3","volume":"55","author":"JF Schlender","year":"2016","unstructured":"Schlender JF, Meyer M, Thelsen K, et al. Development of a whole-body physiologically based pharmacokinetic approach to assess the pharmacokinetics of drugs in elderly individuals. Clin Pharmacokinet. 2016;55:1573\u201389.","journal-title":"Clin Pharmacokinet"},{"key":"1313_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.56.2.4","volume":"56","author":"AJ McLean","year":"2004","unstructured":"McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56:163\u201384.","journal-title":"Pharmacol Rev"},{"key":"1313_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2003","unstructured":"Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol. 2003;57:6\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"1313_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/00003088-200847050-00002","volume":"47","author":"JM Butler","year":"2008","unstructured":"Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. Clin Pharmacokinet. 2008;47:297\u2013321.","journal-title":"Clin Pharmacokinet"},{"key":"1313_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1067\/mcp.2002.121829","volume":"71","author":"LZ Benet","year":"2002","unstructured":"Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. 2002;71:115\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"1313_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1874192401105010130","volume":"5","author":"GM Currie","year":"2011","unstructured":"Currie GM, Wheat JM, Kiat H. Pharmacokinetic considerations for digoxin in older people. Open Cardiovasc Med J. 2011;5:130\u20135.","journal-title":"Open Cardiovasc Med J"},{"issue":"1","key":"1313_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.ackd.2015.08.004","volume":"23","author":"A Denic","year":"2016","unstructured":"Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19\u201328.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"1313_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ki.2012.65","volume":"82","author":"RJ Glassock","year":"2012","unstructured":"Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. 2012;82(3):270\u20137.","journal-title":"Kidney Int"},{"issue":"12","key":"1313_CR12","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/gerona\/gls157","volume":"67","author":"JE Wiggins","year":"2012","unstructured":"Wiggins JE. Aging in the glomerulus. J Gerontol A Biol Sci Med Sci. 2012;67(12):1358\u201364.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1313_CR13","unstructured":"Ewing AB. Altered drug response in the elderly. In: Armour D, Cairns C, editors. Medicines in the elderly. London: Pharmaceutical Press; 2002."},{"key":"1313_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4140\/TCP.n.2008.324","volume":"23","author":"JC Delafuente","year":"2008","unstructured":"Delafuente JC. Pharmacokinetic and pharmacodynamic alterations in the geriatric patient. Consult Pharm. 2008;23:324\u201334.","journal-title":"Consult Pharm"},{"key":"1313_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/01.mjt.0000183719.84390.4d","volume":"14","author":"ES El Desoky","year":"2007","unstructured":"El Desoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther. 2007;14:488\u201398.","journal-title":"Am J Ther"},{"key":"1313_CR16","unstructured":"Kostrzewski A. Cardiovascular medicines in the elderly. In: Armour D, Cairns C, editors. Medicines in the elderly. London: Pharmaceutical Press; 2002."},{"issue":"10","key":"1313_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2165\/00003088-200140100-00005","volume":"40","author":"E Yukawa","year":"2001","unstructured":"Yukawa E, Suematu F, Yukawa M, et al. Population pharmacokinetics of digoxin in Japanese patients. A 2-compartment pharmacokinetic model. Clin Pharmacokinet. 2001;40(10):773\u201381.","journal-title":"Clin Pharmacokinet."},{"issue":"6","key":"1313_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/aps.2010.51","volume":"31","author":"XD Zhou","year":"2010","unstructured":"Zhou XD, Gao Y, Guan Z, et al. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice. Acta Pharmacol Sin. 2010;31(6):753\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"1313_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s13318-012-0107-8","volume":"38","author":"R Chen","year":"2013","unstructured":"Chen R, Zou SL, Wang ML, et al. Population pharmacokinetics of digoxin in elderly patients. Eur J Drug Metab Pharmacokinet. 2013;38(2):115\u201321.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1313_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40780-015-0023-6","volume":"1","author":"T Komatsu","year":"2015","unstructured":"Komatsu T, Morita M, Miyaji F, et al. Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients. J Pharm Health Care and Sci. 2015;1:25.","journal-title":"J Pharm Health Care and Sci."},{"issue":"3","key":"1313_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.clinthera.2014.01.019","volume":"36","author":"SA Choi","year":"2014","unstructured":"Choi SA, Yun HY, Lee ES, et al. A population pharmacokinetic analysis of the influence of nutritional status of digoxin in hospitalized Korean patients. Clin Ther. 2014;36(3):389\u2013400.","journal-title":"Clin Ther"},{"key":"1313_CR22","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2165\/11594230-000000000-00000","volume":"28","author":"M Yukawa","year":"2011","unstructured":"Yukawa M, Yukawa E, Suematsu F, et al. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy. A population pharmacokinetic analysis using nonlinear mixed-effects modelling. Drug Aging. 2011;28:831\u201341.","journal-title":"Drug Aging."},{"issue":"1","key":"1313_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00007691-199602000-00008","volume":"18","author":"LA Bauer","year":"1996","unstructured":"Bauer LA, Horn JR, Pettit H. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations. Ther Drug Monit. 1996;18(1):46\u201352.","journal-title":"Ther Drug Monit"},{"issue":"9","key":"1313_CR24","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.clinthera.2020.07.011","volume":"42","author":"P Du","year":"2020","unstructured":"Du P, et al. Impact of SLCO4C1 genotypes, creatinine, and spironolactone on digoxin population pharmacokinetic variables in patients with cardiac insufficiency. Clin Ther. 2020;42(9):1799-810.e3.","journal-title":"Clin Ther"},{"issue":"6","key":"1313_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5414\/CPP38291","volume":"38","author":"NV Nagaraja","year":"2000","unstructured":"Nagaraja NV, Park YJ, Jeon S, Sands CD, Derendorf H. Population pharmacokinetics of digoxin in Korean patients. Int J Clin Pharmacol Ther. 2000;38(6):291\u20137.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"1313_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/j.1552-4604.1996.tb04196.x","volume":"36","author":"LD Carlton","year":"1996","unstructured":"Carlton LD, Patterson JH, Mattson CN, Schmith VD. The effects of epoprostenol on drug disposition I: a pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure. J Clin Pharmacol. 1996;36(3):257\u201364.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"1313_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2165\/00003088-199222010-00006","volume":"22","author":"PJ Williams","year":"1992","unstructured":"Williams PJ, Lane J, Murray W, Mergener MA, Kamigaki M. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling. Clin Pharmacokinet. 1992;22(1):66\u201374.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"1313_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/BF01061728","volume":"5","author":"LB Sheiner","year":"1977","unstructured":"Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977;5(5):445\u201379.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"9","key":"1313_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.2042-7158.1992.tb05515.x","volume":"44","author":"E Yukawa","year":"1992","unstructured":"Yukawa E, Mine H, Higuchi S, Aoyama T. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens. J Pharm Pharmacol. 1992;44(9):761\u20135.","journal-title":"J Pharm Pharmacol"},{"key":"1313_CR30","doi-asserted-by":"crossref","unstructured":"Hornestam B, Jerling M, Karlsson MO, Held P, DAAf Trial Group. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic\/ pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial. Eur J Clin Pharmacol. 2003;58(11):747\u201355.","DOI":"10.1007\/s00228-002-0553-3"},{"issue":"5","key":"1313_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/bdd.306","volume":"23","author":"F Suematsu","year":"2002","unstructured":"Suematsu F, Yukawa E, Yukawa M, et al. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis. Biopharm Drug Dispos. 2002;23(5):173\u201381.","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"1313_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/j.1552-4604.1997.tb04766.x","volume":"37","author":"E Yukawa","year":"1997","unstructured":"Yukawa E, Honda T, Ohdo S, et al. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. J Clin Pharmacol. 1997;37(2):92\u2013100.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"1313_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2710.2002.00418.x","volume":"27","author":"H Konishi","year":"2002","unstructured":"Konishi H, Shimizu S, Chiba M, et al. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance. J Clin Pharm Ther. 2002;27(4):257\u201365.","journal-title":"J Clin Pharm Ther"},{"key":"1313_CR34","unstructured":"Beal SL, Sheiner LB, Boeckmann AJ, Bauer RJ, editors. NONMEM 7.4 users guides. (ICON plc, Gaithersburg, MD, 1989\u20132018)."},{"key":"1313_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","volume":"1","author":"RJ Keizer","year":"2011","unstructured":"Keizer RJ, Van Benten M, Beijnen JH, et al. Pira\u00f1a and PCluster: a modeling environment and cluster infrastructure for NONMEM. Comput Methods Programs Biomed. 2011;1:72\u20139.","journal-title":"Comput Methods Programs Biomed"},{"key":"1313_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79:241\u201357.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"1313_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO. Xpose\u2014an S-PLUS based population pharmacokinetic\/ pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999;58(1):51\u201364.","journal-title":"Comput Methods Programs Biomed"},{"key":"1313_CR38","unstructured":"Beckman Coulter. SYNCHRON Chemistry Information System sheet. 2015. https:\/\/www.beckmancoulter.com\/wsrportal\/techdocs?docname=\/cis\/A18505\/%25%25\/EN_Ig-A.pdf."},{"key":"1313_CR39","unstructured":"Automated COBAS method of Electrochemiluminescence Immunoassay (ECLIA) patented by Roche Diagnostics\u00ae (version 2.0), 2017."},{"key":"1313_CR40","doi-asserted-by":"crossref","unstructured":"Keizer RJ, Karlsson MO, Hooker A. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacomet. Syst. Pharmacol. 2, e50.","DOI":"10.1038\/psp.2013.24"},{"issue":"4","key":"1313_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF01060893","volume":"9","author":"LB Sheiner","year":"1981","unstructured":"Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1981;9(4):503\u201312.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"7","key":"1313_CR42","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/bcp.14272","volume":"86","author":"M Abdel Jalil","year":"2020","unstructured":"Abdel Jalil M, Abdullah N, Alsous M, et al. A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. Br J Clin Pharmacol. 2020;86(7):1267\u201380.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1313_CR43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s13318-021-00672-6","volume":"46","author":"M Abdel Jalil","year":"2021","unstructured":"Abdel Jalil M, Abdullah N, Alsous M, et al. Population pharmacokinetic studies of digoxin in adult patients: a systematic review. Eur J Drug Metab Pharmacokinet. 2021;46(3):325\u201342.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"6","key":"1313_CR44","first-page":"359","volume":"46","author":"AL Salcedo-Mingoarranz","year":"2022","unstructured":"Salcedo-Mingoarranz AL, Garc\u00eda-D\u00edaz B, Barcia-Hern\u00e1ndez E. Population pharmacokinetics of digoxin in elderly patients: a systematic review. Farm Hosp. 2022;46(6):359\u201366.","journal-title":"Farm Hosp"},{"issue":"144","key":"1313_CR45","volume":"23","author":"R Rivoirard","year":"2014","unstructured":"Rivoirard R, Chargari C, Trone JC, et al. General management of nonagenarian patients: a review of the literature. Swiss Med Wkly. 2014;23(144): w14059.","journal-title":"Swiss Med Wkly"},{"issue":"7","key":"1313_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4933-7-6","volume":"27","author":"IM Rea","year":"2010","unstructured":"Rea IM. BELFAST nonagenarians: nature or nurture? Immunological, cardiovascular and genetic factors. Immun Ageing. 2010;27(7):6.","journal-title":"Immun Ageing."},{"issue":"3","key":"1313_CR47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/acel.12058","volume":"12","author":"J Jylh\u00e4v\u00e4","year":"2013","unstructured":"Jylh\u00e4v\u00e4 J, Nevalainen T, Marttila S, et al. Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty. Aging Cell. 2013;12(3):388\u201397.","journal-title":"Aging Cell"},{"issue":"2","key":"1313_CR48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00000433-200106000-00007","volume":"22","author":"SM John","year":"2001","unstructured":"John SM, Koelmeyer TD. The forensic pathology of nonagenarians and centenarians: do they die of old age? (The Auckland experience). Am J Forensic Med Pathol. 2001;22(2):150\u20134.","journal-title":"Am J Forensic Med Pathol."},{"issue":"3","key":"1313_CR49","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/gerona\/gln037","volume":"64","author":"MC Odden","year":"2009","unstructured":"Odden MC, Shlipak MG, Tager IB. Serum creatinine and functional limitation in elderly persons. J Gerontol A Biol Sci Med Sci. 2009;64(3):370\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1313_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.ajkd.2005.05.011","volume":"46","author":"JC Verhave","year":"2005","unstructured":"Verhave JC, Fesler P, Ribstein J, et al. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis. 2005;46:233\u201341.","journal-title":"Am J Kidney Dis"},{"key":"1313_CR51","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/j.1875-9114.2012.01098.x","volume":"32","author":"MA Winter","year":"2012","unstructured":"Winter MA, Guhr KN, Berg GM. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy. 2012;32:604\u201312.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1313_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00540-018-2596-3","volume":"33","author":"M Matsuo","year":"2019","unstructured":"Matsuo M, Yamagishi F. Age-dependent error in creatinine clearance estimated by Cockcroft\u2013Gault equation for the elderly patients in a Japanese hospital: a cross-sectional study. J Anesth. 2019;33(1):155\u20138.","journal-title":"J Anesth"},{"key":"1313_CR53","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1681\/ASN.2007020199","volume":"18","author":"LA Stevens","year":"2007","unstructured":"Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18:2749\u201357.","journal-title":"J Am Soc Nephrol"},{"key":"1313_CR54","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"issue":"1","key":"1313_CR55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/fcp.12241","volume":"31","author":"E Cartet-Farnier","year":"2017","unstructured":"Cartet-Farnier E, Goutelle-Audibert L, Maire P, et al. Implications of using the MDRD or CKD-EPI equation instead of the Cockcroft-Gault equation for estimating renal function and drug dosage adjustment in elderly patients. Fundam Clin Pharmacol. 2017;31(1):110\u20139.","journal-title":"Fundam Clin Pharmacol"},{"key":"1313_CR56","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/ndt\/gfm289","volume":"22","author":"J Gill","year":"2007","unstructured":"Gill J, Malyuk R, Djurdjev O, et al. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group: a cautionary tale. Nephrol Dial Transplant. 2007;22:2894\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1313_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF01059771","volume":"21","author":"JR Wade","year":"1993","unstructured":"Wade JR, Kelman AW, Howie CA, Whiting B. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis. J Pharmacokinet Biopharm. 1993;21:209\u201322.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"7\u20138","key":"1313_CR58","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1345\/aph.1S176","volume":"47","author":"DL Brown","year":"2013","unstructured":"Brown DL, Masselink AJ, Lalla CD. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation. Ann Pharmacother. 2013;47(7\u20138):1039\u201344.","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01313-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-023-01313-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01313-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T02:18:55Z","timestamp":1701224335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-023-01313-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1313"],"URL":"https:\/\/doi.org\/10.1007\/s40262-023-01313-8","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"assertion":[{"value":"22 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article was produced without receiving funding or any grants, consultancies, honoraria, or payment related to speakers' bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no potential conflicts of interest, including relevant financial interests, activities, relationships, and affiliations with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article was approved by the Ethics Committee of the Severo Ochoa University Hospital (ID number: ASM-DIG-2020-01).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors were involved in data collection, formal analysis, and manuscript writing, review, and editing. All authors have read and agreed to the published version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The authors declare that this paper is original and has not been previously published, nor is it in the process of being reviewed by any other journal.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous presentation of the information reported in the manuscript"}}]}}